Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
9.74
+0.88 (9.93%)
At close: Jan 16, 2026, 4:00 PM EST
9.95
+0.21 (2.16%)
After-hours: Jan 16, 2026, 6:29 PM EST
Kalaris Therapeutics Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$20.67
Upside
+112.22%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Initiates $19 | Strong Buy | Initiates | $19 | +95.07% | Dec 23, 2025 |
| Citizens | Citizens | Buy Initiates $20 | Buy | Initiates | $20 | +105.34% | Nov 3, 2025 |
| Raymond James | Raymond James | Strong Buy Initiates $23 | Strong Buy | Initiates | $23 | +136.14% | Sep 3, 2025 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Apr 8, 2025 |